Pluri Inc. Files 8-K on Security Holder Rights
Ticker: PLUR · Form: 8-K · Filed: Apr 1, 2024 · CIK: 1158780
| Field | Detail |
|---|---|
| Company | Pluri Inc. (PLUR) |
| Form Type | 8-K |
| Filed Date | Apr 1, 2024 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.00001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing-update
TL;DR
Pluri Inc. filed an 8-K detailing changes to shareholder rights and corporate bylaws.
AI Summary
Pluri Inc. filed an 8-K on March 27, 2024, reporting material modifications to the rights of its security holders and amendments to its articles of incorporation or bylaws. The filing also includes financial statements and exhibits. The company, formerly known as Pluristem Therapeutics Inc., is incorporated in Nevada and operates in the biological products sector.
Why It Matters
This filing indicates potential changes affecting Pluri Inc.'s shareholders and corporate structure, requiring investors to review the details of the modifications and amendments.
Risk Assessment
Risk Level: medium — Filings related to modifications of security holder rights and amendments to corporate documents can introduce uncertainty and impact shareholder value.
Key Players & Entities
- Pluri Inc. (company) — Registrant
- Pluristem Therapeutics Inc. (company) — Former company name
- March 27, 2024 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of incorporation
FAQ
What specific modifications were made to the rights of Pluri Inc.'s security holders?
The filing indicates material modifications to the rights of security holders, but the specific details are not provided in this summary section of the 8-K.
What amendments were made to Pluri Inc.'s articles of incorporation or bylaws?
The filing states that amendments were made to the articles of incorporation or bylaws, but the specific nature of these amendments is not detailed in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on March 27, 2024.
What is Pluri Inc.'s former company name?
Pluri Inc. was formerly known as Pluristem Therapeutics Inc.
In which U.S. state is Pluri Inc. incorporated?
Pluri Inc. is incorporated in Nevada.
Filing Stats: 1,170 words · 5 min read · ~4 pages · Grade level 11 · Accepted 2024-04-01 07:00:32
Key Financial Figures
- $0.00001 — h registered Common Shares, par value $0.00001 per share PLUR The Nasdaq Capital M
Filing Documents
- ea0202857-8k_pluriinc.htm (8-K) — 31KB
- ea020285701ex3-1_pluriinc.htm (EX-3.1) — 4KB
- ea020285701ex3-2_pluriinc.htm (EX-3.2) — 1KB
- ex3-1_001.jpg (GRAPHIC) — 855KB
- ex3-2_001.jpg (GRAPHIC) — 346KB
- 0001213900-24-028192.txt ( ) — 1864KB
- plur-20240327.xsd (EX-101.SCH) — 3KB
- plur-20240327_lab.xml (EX-101.LAB) — 33KB
- plur-20240327_pre.xml (EX-101.PRE) — 22KB
- ea0202857-8k_pluriinc_htm.xml (XML) — 4KB
03 Material Modification to Rights of Security Holders
Item 3.03 Material Modification to Rights of Security Holders. On March 27, 2024, Pluri Inc. (the "Company") filed a Certificate of Change (the "Certificate") with the secretary of state of Nevada relating to a 1-for-8 reverse share split of the Company's authorized common shares, which will take effect on April 1, 2024 (the "Reverse Split"). Effects of the Reverse Split Effective Date; Symbol; CUSIP Number . The Reverse Split will be effective at 12:01 a.m. Eastern Standard Time on April 1, 2024, and will be reflected with the Nasdaq Capital Market ("Nasdaq") and in the marketplace at the open of business on April 1, 2024 (the "Effective Date"), whereupon the common shares will begin trading on a split-adjusted basis. In connection with the Reverse Split, the Company's common shares will continue to trade on Nasdaq under the symbol "PLUR" but will trade under a new CUSIP Number, 72942G203. Split Adjustment; No Fractional Shares . On the Effective Date, the total number of the Company's common shares held by each shareholder were converted automatically into the number of whole common shares equal to the number of issued and outstanding common shares held by such shareholder immediately prior to the Reverse Split, divided by eight (8). No fractional shares will be issued, and no cash or other consideration will be paid. Instead, the Company will issue one additional whole share of the post-Reverse Split to any shareholder who otherwise would have received a fractional share as a result of the Reverse Split. effected by the Company filing the Certificate pursuant to Nevada Revised Statutes ("NRS") Section 78.209 with the Secretary of State of the State of Nevada on March 27, 2024. The Certificate was not effective until the Effective Date. Under Nevada law, no amendment to the Company's Articles of Incorporation is required in connection with the Reverse Split. A copy of the Certificate is attached hereto as Exhibit 3.1 an
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PLURI INC. Date: April 1, 2024 By: /s/ Chen Franco-Yehuda Name: Chen Franco-Yehuda Title: Chief Financial Officer 2